These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


396 related items for PubMed ID: 18161160

  • 1. [Osteoporosis in patients with diabetes mellitus].
    Yamauchi M.
    Nihon Rinsho; 2007 Nov 28; 65 Suppl 9():526-30. PubMed ID: 18161160
    [No Abstract] [Full Text] [Related]

  • 2. [Primary osteoporosis--its diagnosis and treatment].
    Inaba M.
    Nihon Rinsho; 2007 Nov 28; 65 Suppl 9():485-9. PubMed ID: 18161153
    [No Abstract] [Full Text] [Related]

  • 3. [Diagnosis and treatment of osteoporosis in men].
    Hosoi T.
    Nihon Rinsho; 2007 Nov 28; 65 Suppl 9():495-8. PubMed ID: 18161155
    [No Abstract] [Full Text] [Related]

  • 4. [Vitamin K2 treatment for osteoporosis: what is the evidence today?].
    Ishida Y.
    Nihon Rinsho; 2007 Nov 28; 65 Suppl 9():409-14. PubMed ID: 18161141
    [No Abstract] [Full Text] [Related]

  • 5. [Image assessment of the treatment effect on osteoporosis: bisphosphonates].
    Sone T.
    Clin Calcium; 2011 Jul 28; 21(7):1041-6. PubMed ID: 21719985
    [Abstract] [Full Text] [Related]

  • 6. [Diagnosis and treatment of immobilization osteoporosis].
    Inoue D.
    Nihon Rinsho; 2007 Nov 28; 65 Suppl 9():514-9. PubMed ID: 18159714
    [No Abstract] [Full Text] [Related]

  • 7. [Diagnosis and treatment of glucocorticoid-induced osteoporosis in collagen vascular disease].
    Kawano S, Kumagai S.
    Nihon Rinsho; 2007 Nov 28; 65 Suppl 9():504-7. PubMed ID: 18161157
    [No Abstract] [Full Text] [Related]

  • 8. [Outline of Guidelines 2004 for bone marker in osteoporosis].
    Nishizawa Y.
    Nihon Rinsho; 2007 Nov 28; 65 Suppl 9():37-41. PubMed ID: 18161079
    [No Abstract] [Full Text] [Related]

  • 9. [Measurement of bone mineral density is unnecessary for monitoring of bisphosphonate treatment].
    Nishida A, Ito M.
    Clin Calcium; 2011 Jan 28; 21(1):120-3. PubMed ID: 21187605
    [Abstract] [Full Text] [Related]

  • 10. Underdiagnosis and under-treatment of osteoporosis following fragility fracture.
    Aboyoussef M, Vierkoetter KR.
    Hawaii Med J; 2007 Jul 28; 66(7):185-7. PubMed ID: 17879856
    [Abstract] [Full Text] [Related]

  • 11. Clinical practice. Osteoporosis in men.
    Ebeling PR.
    N Engl J Med; 2008 Apr 03; 358(14):1474-82. PubMed ID: 18385499
    [No Abstract] [Full Text] [Related]

  • 12. Effect of zoledronic acid on markers of bone turnover and mineral density in osteoporotic patients with beta-thalassaemia.
    Perifanis V, Vyzantiadis T, Tziomalos K, Vakalopoulou S, Garipidou V, Athanassiou-Metaxa M, Harsoulis F.
    Ann Hematol; 2007 Jan 03; 86(1):23-30. PubMed ID: 17013645
    [Abstract] [Full Text] [Related]

  • 13. [Diagnosis and treatment of steroid-induced osteoporosis in respiratory diseases].
    Nagasaka Y, Ieda Y.
    Nihon Rinsho; 2007 Nov 28; 65 Suppl 9():509-13. PubMed ID: 18161158
    [No Abstract] [Full Text] [Related]

  • 14. Bone density vs bone quality: what's a clinician to do?
    Licata A.
    Cleve Clin J Med; 2009 Jun 28; 76(6):331-6. PubMed ID: 19487553
    [Abstract] [Full Text] [Related]

  • 15. [Evidence of alendronate treatment for osteoporosis].
    Harada A.
    Nihon Rinsho; 2007 Nov 28; 65 Suppl 9():337-43. PubMed ID: 18161127
    [No Abstract] [Full Text] [Related]

  • 16. [Diabetes Mellitus and bone metabolism].
    Okazaki R.
    Clin Calcium; 2011 May 28; 21(5):669-75. PubMed ID: 21532115
    [Abstract] [Full Text] [Related]

  • 17. [Contemporary diagnostics and therapy of osteoporosis].
    Vogel T, Bitterling H, Dobler T, Bartl R, Pfeifer KJ, Mutschler W.
    Zentralbl Chir; 2006 Oct 28; 131(5):401-6. PubMed ID: 17089289
    [Abstract] [Full Text] [Related]

  • 18. [Therapeutic considerations on secondary osteoporosis caused by diabetes mellitus].
    Azuma K.
    Clin Calcium; 2009 Sep 28; 19(9):1345-52. PubMed ID: 19721208
    [Abstract] [Full Text] [Related]

  • 19. [New bone density conservation agents for osteoporosis under research and development: ED-71].
    Hagino H.
    Nihon Rinsho; 2007 Nov 28; 65 Suppl 9():454-8. PubMed ID: 18161148
    [No Abstract] [Full Text] [Related]

  • 20. [Management of osteoporosis by using biochemical markers for bone turnover].
    Mizunuma H.
    Nihon Rinsho; 2007 Nov 28; 65 Suppl 9():227-30. PubMed ID: 18159710
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.